Document x1BzQNNy9X13rqvMYRvqZDGd0
c Cr'V'. ' S 2*/
NATIONAL CANCER INSTITUTE MONOGRAPH 59 April 1982
Cancer Mortality in the United States: 1950--1977
NIH Publication No. 82-2435 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES
PUBLIC HEALTH SERVICE NATIONAL INSTITUTES OF HEALTH NATIONAL CANCER INSTITUTE, BETHESDA, MARYLAND 20205
' URL 05479
NATIONAL CANCER INSTITUTE MONOGRAPHS
Vincent T. DeVita, Jr., Director, National Cancer Institute
The Editorial Board welcomes proposals for the publication of monographs. However, the subject matter must be relevant!*-cancer research, have long-term interest, appeal to a wide readership, and be of quality meeting the standards of the Journal ofthe National Cancer Institute, Proposals should be sent to the Editor in Chief as early as possible, preferably several months before a conference (for conference proceedings) or before preparation of a final draft.
Because the data presented in this volume will be widely used as a reference source, the Board of Editors has approved its publication as a logical sequel to our Monograph No. 33, "Patterns in Cancer Mortality in the United States: 1950-1967."
BOARD OF EDITORS Peter Greenwald, Editor in Chief Elizabeth K. Weisburger, Assistant Editor in Chief
Stuart A. Aaronaon, Associate Editor Charles H. Evans. Associate Editor Mary Fink, Associate Editor Janet W. Hartley, Associate Editor Donald Henson, Associate Editor Ronald B. Herberman, Associate Editor
George S. Johnson, Associate Editor Kurt W. Kohn, Associate Editor Arthur S. Levine, Associate Editor John J. Mulvihill, Associate Editor Alan S. Rakson, Associate Editor Richard M. Simon, Associate Editor
URL 05480-
For sale ONLY by the Superintendent of Documents, U.S. Government Printing Office, Washington, D.C 20402.
CANCER MORTALITY IN THE UNITED STATES: 1950-1977
URL 05481
Clinical Epidemiology Branch Field Studies and Statistics Program Division of Cancer Cause and Prevention Nationol Cancer Institute National Institutes of Health
frank W. McKay Margot R. Hanson
Robert W. Miller
Foreword................................................................................. -.............................................. .
Introduction
............
Methods !
........ .
AU Malignant Neoplasms....................-...................................................................................
Lip .......................................................... ..................................................................................
Salivary............................................................ ................ .......................................................
Floor of Mouth............ ................................................................ ..... ...................................... Oral Mesopharynx...... .......................................... ................................................................... Nasopharynx...--.................................................................................................................... .
Hypopharynx............................................................................... ............................................. Pharynx Unspecified....................................................-........................................................... Buccal Cavity Plus Oral Pharynx...................................................................... ................... . Esophagus.......................................................................................... ....................................... Stomach.............................................................. .......................................... ........................... Small Intestine........................................................................................................................... Large Intestine.................................................................................................... ........ ....... .....
Rectum............. ......... ...... ........................................................................................................ Biliary Passages and Liver (Primary)......................................................................................
Pancreas ............ ..................................................................................................... ................. Peritoneum......................................................................... ......................................................
Now.......................................................................................................................................... Larynx.................. ..................................................................................................................... Bronchus, Trachea, and Lung..................................................................................... ...........
Breast...................................................................................... .............................................. . Uterine Cervix........................................................................................................................... Body of Uterus.............................................................................. ............... .......... .................
Ovary, Uterine Tube, etc......................................................................................................... Prostate................................................................................................ .................................... Testis......................................................................................................................................... Kidney ............. .................................................................................................................... Bladder and Other Urinary Organs.................................................................. ....................... Melanoma........................................................................ ........................................................ .
Skin........ ........... ....................................................................................................................... Eye............................................................................................................................................ t Nervous System....................................................................................................................... TTiyroid ...................................................................................................................................
' Bone.........................................................................................................................................
Connective Tissue............................................................... .................................................... Hodgkin's Disease............................................................... .................................................... Non-Hodgkin's Lymphoma.....................................................................................................
Multiple Myeloma.................................................................................................................... All Leukemia............................................................................................................................ Ail Mortality............................................................................................................................ Populations..............................................................................................................................
Appendix I--Annual Tumor Mortality by the 1CD......... ............................................ ..........................Appendix 11--Sixth, Seventh, and Eighth Revisions of the ICD for Cancer..... ............................. .... Appendix III--Accuracy of Cancer Death Certificates and its Effect on Cancer Mortality Statistics.
iii
v
2
12
18 24
30
36
42
48
54
60
70
80
90
96
106
116
126
136
142
148
154
164
C. XI--5
174 180
184
* 190
CO
tn>
196
202
212
222
232
238
244
254
260
270
280
290 300
310
320
330
340 450
467
Bladder and Other Urinary Glands
Age-adjusted Mortality Rates
h
+ *HHITE HALES KbHHITE FEMALES sNONWHJTE MIES QbNONHHITE FEMALES
URL 05483
u ^..... ............................................................................................
^60
1955
I960
1965
CALENDAR YEARS
1970
1975
1950
1953
1955 1955 1957 1955 1959 1950 1951 1952 1953 1955 1955 1955 1957 1955 1959 1970 1971 1972 1973 1975 1975 1975 1977
mn III!-- -- C7"02 ADJ. 5 or turn UTI Mil flftUO*
101
5339
535 597 *597 787 750
5080 5039 5203 5281 5115 5187 53*2 557* 5831 5579 5880 5855 39*2 8009 8152 8225 5309 839
8.05 8. 21 5. 20 8.29 8. 29 8.30 5.33 5. 19 8. 33 8.B1 8.25 8.39 8.0 8.12 5.1* 8.27 8. *8 8.50 8.39 8.55 8. 38 8.50 8.59 8.12 5.85 5.91 8.92
7.33 7.28 7.0 7.33
7.31 7.3$ 7.3* 7.17 7.3J 7.36 7.17 7.Z8 7.38 7.05 7.02 7.21 7.37 7. *0 7.22 7.50 7. IS 7.37 7. *1 7.*9 7.*5 7. *3 7.36
38 30
30 22 2* 1* 10 09 05 09 * 07 3 93 3 98 3 95 3 79 3 70 3 70 3 02 3 79 3 70 3 81 3 59 3 58 3 59 3 57 3 88 3 80 3 S*
---- hits iriAis-- TOTJkl oods AOJ. % or SttTIS UTS UTS use*
-on x* III-- TOTAL cross AM. i or SSATlI tits UTS mss*
TOTAL StATBS
1071 1989 1971 2 010 2000 212 2070 2137 2079 2127 2158 2195 2233 2255 2227 2390 227* 2005 2315 2377 258* 2M 1200 2529 2591 2532 2881 2793
2.75 2.73 2.90 2.81 2.75 2* 97 2.7 2.79 2.58 2.58 2.87 2.87 2.88 2. 87 2.80 3.75 2.59 2.71 2.59 2.53 2.90 2. 85 2.80 2.70 2.75 2. 87 2.01 2.91
3.05 3. 02 3.03 3.01 2.09 2.97 3.82 3.92 3.88 3.63 3.60 3.57 3. 58 3.50 2.0 3.51 3.31 3. 30 3.23 3.33 3. 33 3. 16 3.08 3.13 3. 13 3.02 3.00 3.13
2.09 2.09 2.09 2.09 3.09 2.11 2.02 3.03 1.96 1.96 1.9* 1.93 1.91 1.09 1.93 1.91 1.77 1.92 1.71 1.71 1.79 1.66 1.59 1.6 1.63 1.55 1.57 1.59
1 | | 1 | 1 I 1 1 1 | | | 1 1 i | 1 | I t | | 1 | I | t
2*9 3.30 93 1.27 |
179
272 3.2 5.0 3.32 |
>62
361 3.39 8.91 3.10 | 173
293 3. 1 5. 0* 3.12 ( 207
390 3.81 5.08 2.98 | 205
360 3.99 .2 2.62 | 173
302 3.39 X 15 2.99 1 207
338 3.57 S. 23 3.97 | 236
32* 3.5 5.11 2.97 | 226
3* 3.59 5.29 2.92 1 225
360 3.59 5.28 2.77 | 289
178 3. 85 5. 39 2.79 | 225
373 3. 5.22 2.67 i 273
07 3.79 5.87 2.76 | 246
375 3.2 .98 2.*5 | 286
399 3.57 5.31 2.39 1 2*3
38 3. 92 5.95 2.72 | *73
S 3.9* 3.73 2.82 | 337
2 3.75 5.62 2.49 | 287
73 X 95 6.02 2.8* | 291
77 X 91 5.90 2.58 l 205
79 3.98 5.82 2.53 j 303
2*9 3.91 5.91 2.51 <
172
71 3.95 5.55 2.29 | 326
99 3.73 5.39 2.26 | 335
55 3.87 5.21 2.10 | 339
535 3.92 5.79 2.29 | }U
517 X 72 5.63 2.18 | 349
cross tATS
2.21 1.96 2.0 3.39 2.20 1.90 2.21 2.46 2.29 2.22 2.5* 2.07 2.as 2. 16 2.20 2.39 2.24 2.71 2.27 2. 19 2. 16 2. 25 2.50 2.33 2.35 2.33 2.29 2.30
'Age-adjusted rate as percent of age-adjusted rate for all malignant neoplasms.
ASJ. 5 or OATS It ALIO*
3.16 2.8* X02 3.43 3.3* 2.79 X04 3.*9 3.18 x to 3.5* 2.90 3.43 3.0 1 3. 17 3.28 3.10 3.6 X02 2.92 2.96 2.9* 3.2* 3.00 3.03 2.95 X 96 2.83
2 . to 1.97 2. 09 2.0
1.96 2.09 2.62 2.20 2.22 2.45 3.02 2.as 2. 16 2. 25 2.32 2. 17 2.56 3. 11 3.07 2.08 2.05 3. 39 3.0* 3.09 3.06
1.91
Includes: Bladder, urachus, urethra, and other urinary organs (NOS). (ICO 161 (6th]; ICO 191-161.8 [7th}; ICO 196,199.9 (8th]>
212
i, >' .fc'-v
.X \
* -.
V-
h \,-(wr.
NATIONAL CANCER INSTITUTE MONOGRAPH NO. 59
Bladder and Other Urinary Glands
Age-specific Rates White Males
White Females
URL 05484
Nonwhite Males
Nonwhite Females
COLE P: Lower urinary tract. In Cancer Epidemiology end Prevention: Current Concepts (Schottenfeld D, ed). Springfield, III: Charles C Thomas, 1975, pp 235-262
CANCER MORTALITY IN THE U.S., 1950-1977
213
Kidney
Age-adjusted Mortality Rates
c
33 o
s0<j3y
itso t HI
1952 1H) 1*
1955 1*56
1*57
1 *SS 1*5* 1*50 1961 1962
1963
196* 1965 1 966 1967
1966
1969 1970 1971
1972 1973 1976
1975 1976 1977
--------- tltltt mt-- ... TOTAL CHOP* 6DJ. % or tuns UTI a it i siiie>
..... 9IXTK KIUK90961 CI0B1 IN. 0 OP Btt9M 1*7* 1691 66610*
-09*36 611--*-- TOT6L C30DS 6DJ. t or
036909 691 2693 ui:*
...----------otin mm..
90961 COOOB 6DJ. I OP
006906 0691 6TB 1 6110*
2126 2157
23 17 23* 1 2*53 2551 26 2 6
2720 3761
3*75 29*6 20*3 3015
3219 3250 3266 3657
3*01 3577
36*1 3701 3790
1961 3619
025 399* *066 *23*
3. 1* 3. U
3.32 3. 37
3. *0 3. *6 3. 53 3.59
3.60 3.66 3.72 1.79 3.70
3. 90 3.69 3.67
* .06
3.96 *. 13 *. 17 *.20 . 27
*.39
6.25 *. *6 *.*0 *. *6 *. 61
3.37 3.3*
3.5* 3. 56 3.60 3.66 3.1*
3.60 3.79 3.91 3.93
*.03
3.93
*. 17
*. 15 *. 13 6.36 6.3* .2 6.*7 .S0 6.56 6.67
.*9
9.66 *.56
*.63 6.7*
2.01 1.59 2.06 2.05 2.06 2.06 2.09 2.11 2.1* 2.19 2.17
2.21 2.15
2.2* 2.23 2.16
2.26 2.20 2.27
2.29 2.26 2.29
2.32 2.23 2.29 2.25 2.2* 2.26
| I ) I | 1 | 1 | I |
| |
1 1 1
| | |
| | (
| | ( | | |
1310 1336 1377
1396 1*66 1561 15*4 1653
1666 1666 1669 1602
1621 1S3 1693
1961 2006
3066 3079
2109 3166 2135
1066 32*6
3369 3*57 3*67 3567
1.92 1.93
1.96 1.95 2.01 2.11
2.05 2.15
3. l* 2. 10 2.07 2.20
3.16
3.16 2.21 3.36
2.26 3.31
3.32 2.32 3.37 2.31 2.3*
3.40
2.53 2.59 2.59
3.70
3.00 1. 99 1.99 1.97
3.03 3. 09 3.01
3.10 3.07 2.03 1.97
2.06
2.06 2.0* 2.06 2.11
3.09 2.06 2.00 2.00 3.06 3.01
2.02
3.0* 3.13 3.16
3.11 3.16
1.37 1.37 1.37 1.37
1. *3 1. *9 1.**
1.51 1.52 1.50 l. 7
1.56
1.55 1.5* 1.57
1.60
1.59 1.50 1.59 1.59 1.59 1.55
1.55 1.57 1.61 1.65
1.60 1.6*
| | | |
| | |
t | 1 1
|
| 1 |
1
| 1 | | | 1
| | | 1
1 |
120 117 1*5 135 155 1*5 169 190 301 190 199
226 236 215
252 2*3
22* 293 315 276 396 267
163
201 309 130
353 5*1
1.5* 1.*? 1.79 1.63
1.02 1.67
1.90 2. 00 3. IS 1.90 1.96 2.21
2.17 3.00 2.30 3.16
2.05 2.52 2.67
3.33 3.3
3.31 2.57
2.32 2.35 2. *6 2.50 2.*5
1.91 1.05
2.2* 1.9*
2.22 2.06
3.36 3.61 2.73 3.63 3.5* 3.57
2.0* 2.55
3.04 2.91 3.00
2.41 3.55 3.1* 3.39
3.22
3.55 3.23 9.2* 3. *2 3.59 3.27
1.24 1.33 1.42 1.23 1.30 1.33
1.33 1.43 1.53 1.*0
1.36
1.40
1.46 1.2* 1.50 1.41
1.30 1.56 1.62 1.40 1. *7
1.40
1.55 1.33
1.31 1.30
1.*0 1.31
| | 1 | 1 |
( 1 | |
|
|
| | I |
| | 1 | |
|
| I
i I
I |
09 7
90 90 6 *1
111 9* 113 130
125
1*0 15* 117 137
1*5 146 155
146 M0 160 161
09 173 176
193 209
311
1. 10 1.05 1.04 1.0* 0.99 1.00
1.19 1.02 1.15 1. 16
1. 16 1.39 1.36 1.03
1.1* 1.22
1.30 1.25 1.15 1.30 1.21
1.3*
1.39 1.3* 1.23 1.33
1.41 1.39
1.3* 1.23 1.37 1.26 1.23 1.2* 1.40 1.26 1.36 1.36 1. *6
1.61 1.45
1. 26 1.43 1.50 1.51 1.53 1.40 1.59
1.46 1.6 1 1.56
1.52 1.62 1.61
1.70 1.67
0.90 o.as 0. 95 0. 90 0.66 0.67
0.96 0.67
0.9* 0.99 1.01
1. 12
1.17 0.93 1.03 1.06 1.05 1.07 0. 96 1. 13 1.05
1. 12
1. 11 1.03 1.05 1. 13
1. 16 1. 13
* Age-adjusted rate a* percent of age-adjusted rate for alt malignant neoplasms.
Includes: Kidney and ureter. (ICO ISO [6th], fCD 160 (tthj; ICO 189-188.2 [ftthS
202
NATIONAL CANCER INSTTTUTE MONOGRAPH NO. SO
.Kidney
Agespeciflc Rates White Males
White Females
Nonwhite Males
Nonwhite Females
BLOT WJ, Praumeni JF JR: Geographic pattern* of renal cancer in the United States. JNCI 63:363-366,1979 CANCER MORTALITY IN THE U.S., 1950-1977
203